accountAUXL), a specialty biopharmaceutical company, today announced that the Company received a $7.5 million regulatory milestone from Pfizer, Inc. (Pfizer) following the first sale of XIAPEX�� in Germany, a major EU market. XIAPEX is now available for sale in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Auxilium Pharmaceuticals, Inc. Updates Launch Progress Of XIAPEX�� In EU
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account